117 results

• Wegovy Vision Loss Risks 5 Times Higher Than Ozempic: Study

  March 13, 2026

  Irvin Jackson

  A new study links higher doses of semaglutide, the active ingredient in Ozempic and Wegovy, with increased vision loss risks, with Wegovy carrying five times the risk than Ozempic.

• GLP-1 Gout and Bone Fracture Risks Highlighted in New Studies

  March 10, 2026

  Irvin Jackson

  Two new studies warn that Ozempic, Mounjaro and similar drugs may be linked to increased risks of bone density loss, osteoporosis and gout, particularly in older patients.

• Ozempic NAION Side Effects Led to Blurred Vision, Lawsuit Alleges

  March 3, 2026

  Irvin Jackson

  A lawsuit over the side effects of Ozempic claims it led to a woman developing worsening blurred vision, even after she stopped taking the injections.

• Judge Appoints Attorneys to Leadership Positions in GLP-1 Vision Loss Lawsuits

  February 26, 2026

  Irvin Jackson

  A U.S. District Judge has appointed a group of 16 attorneys to work for the benefit of all plaintiffs with pending federal GLP-1 vision loss lawsuits.

• Study Finds No Link Between Side Effects of GLP-1s and Thyroid Cancer

  February 24, 2026

  Irvin Jackson

  A new report dismisses concerns linking drugs like Ozempic and Mounjaro to increased thyroid cancer risks, despite the drugs carrying a black box warning from the FDA.

• Ozempic, Wegovy NAION Risks Twofold Higher Compared to SGLT2i Drugs: Study

  February 19, 2026

  Irvin Jackson

  Researchers from Veterans' Affairs say that drugs like Ozempic and Wegovy carry double the risk of vision problems than other types of diabetes medications.

• Lawsuit Claims NAION Vision Loss Caused by Ozempic Side Effects

  February 11, 2026

  Irvin Jackson

  An Ozempic NAION vision loss lawsuit claims Novo Nordisk knew, or should have known of the potential side effects for years.

• GLP-1 Vision Loss Lawsuits Can Now Be Filed Directly in MDL Court

  February 2, 2026

  Irvin Jackson

  A federal judge has approved direct filing of new GLP-1 vision loss lawsuits with the MDL court in the Eastern District of Pennsylvania.

• GLP-1 Diabetes Drugs Linked to Increased Risk of Kidney Side Effects

  January 29, 2026

  Irvin Jackson

  A new study finds that GLP-1 medications carry higher risks of long-term kidney damage than drugs like Invokana and Jardiance.

• Ozempic Side Effects Led to Severe Vision Loss, Lawsuit Claims

  January 21, 2026

  Irvin Jackson

  A recent Ozempic NAION lawsuit claims Novo Nordisk knew the drug was linked to vision loss risks for years, but failed to update the label warnings.